Article
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Oncotarget - 24 Jan 2017
Petrachi Tiziana, Romagnani Alessandra, Albini Adriana, Longo Caterina, Argenziano Giuseppe, Grisendi Giulia, Dominici Massimo, Ciarrocchi Alessia, Dallaglio Katiuscia
Abstract excerpt
Melanoma is the most dangerous and treatment-resistant skin cancer. Tumor resistance and recurrence are due to the persistence in the patient of aggressive cells with stem cell features, the cancer stem cells (CSC). Recent evidences have shown that CSC display a distinct metabolic profile as compared to tumor bulk population: a promising anti-tumor strategy is therefore to target specific metabolic pathways...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
